View Author
cancer family brca 1 variant breast mutation study model genetic breast cancer brca 2 number netherland carrier university breast cancer risk research genetics service patient department syndrome control probability analysis centre page number hospital citation purposes cutoff point attitude center member table diagnosis genet sequence germline information population brcapro result service tumor chek 2 cutoff chek 2 gene signi ficantly modifier tumour .1100delc li-fraumeni li-fraumeni syndrome children individual risk family members group proband history point score purpose citation polymorphism brca 2. repair index sample figure association family members regression index patient nevanlinna h xrcc 1 classification relative antoniou grant netherlands cancer institute phenotype
4 Most Recent Publications
|
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(Article)
Osorio, A. Milne, R.L. Konstantopoulou, I. Hogervorst, F.B.L. Verhoef, S. Dooren, M.F. van Jager, A. Ausems, M.G.E.M. Aalfs, C. Asperen, C.J. van Vreeswijk, M.P. Waisfisz, Q. Pallás-Alonso, C.R. Roozendaal, C.E.P. van Ligtenberg, M. Easton, D.F. Peock, S. Cook, M.S. Oliver, C.T. Frost, D. Curzon, B. Evans, D.G. Lalloo, F. Pita, G. Eeles, R. Izatt, L. Davidson, R. Adlard, J.W. Eccles, D. Ong, K.R. Douglas, F. Downing, S. Brewer, C. Walker, L. Peterlongo, P. Nevanlinna, H. Aittomäki, K. Couch, F.J. Fredericksen, Z. Lindor, N.M. Godwin, A.K. Isaacs, C. Caligo, M.A. Loman, N. Jernström, H. Teulé, A. Barbany-Bustinza, G. Liljegren, A. Ehrencrona, H. Stenmark-Askmalm, M. Feliubadaló, L. Manoukian, S. Peissel, B. Zaffaroni, D. Bonanni, B. Fortuzzi, S. Nathanson, K.L. Johannsson, O.T. Chenevix-Trench, G. Chen, X.C. Beesley, J. Spurdle, A.B. Sinilnikova, O. Healey, S. McGuffog, L. Antoniou, A.C. Brunet, J. Domchek, S.M. Radice, P. Benítez, J. Rebbeck, T.R. Lasa, A. |
2011-05-01
|
|
Attitude towards pre-implantation genetic diagnosis for hereditary cancer
(Article)
Lammens, C.R.M. Bleiker, E.M.A. Spruijt, L. Verhoef, S. Gómez García, E.B. Ruijs, M.W.G. Aaronson, N.K. Vriends, A.H.J.T. Jansweijer, M. Ausems, M.G.E.M. Wagner, A. Sijmons, R.H. Ouweland, A.M.W. van den Luijt, R.B. van der |
2009-12-01
|
|
The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
(Article)
Ruijs, M.W.G. Broeks, A. Menko, F. Ausems, M.G.E.M. Wagner, A. Oldenburg, R. Meijers-Heijboer, H. Veer, L.J. van 't Verhoef, S. |
2009-02-17
|
|
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history
(Article)
Gómez García, E.B. Oosterwijk, J.C. Os, T.A.M. van Hout, A.H. van der Ligtenberg, M. Ouweland, A.M.W. van den Luijt, R.B. van der Wijnen, J.T. Gille, J.J.P. Lindsey, P.J. Devilee, P. Blok, M.J. Timmermans, M. Vreeswijk, M.P. Asperen, C.J. van Hogervorst, F.B.L. Hoogerbrugge, N. Oldenburg, R. Verhoef, S. Dommering, C.J. Ausems, M.G.E.M. |
2009-02-06
|